|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
05.02.26 - 14:12
|
IQVIA Q4 Earnings Up; Guides FY26 (AFX)
|
|
|
WASHINGTON (dpa-AFX) - IQVIA Holdings Inc. (IQV), a healthcare data and analytics company, on Thursday reported higher net income and revenue in the fourth quarter compared with the previous year ......
|
|
|
|
|
|
|
|
|
05.02.26 - 13:03
|
IQVIA Reports Fourth-Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance (Business Wire)
|
|
|
Revenue of $4,364 million for the fourth quarter, $16,310 million for the full year
GAAP Net Income of $514 million for the fourth quarter, $1,360 million for the full year
Adjusted EBITDA of $1,046 million for the fourth quarter, $3,788 million for the full year
GAAP Diluted Earnings per Share of $2.99 for the fourth quarter, $7.84 for the full year
Adjusted Diluted Earnings per Share of $3.42 for the fourth quarter, $11.92 for the full year
R&D Solutions quarterly bookings of over $2.7 billion, representing a book-to-bill ratio of 1.18x
R&D Solutions contracted backlog of $32.7 billion, up 5.3% year-over-year
R&D Solutions Revenue of $2,333 million for the fourth quarter, up 9.9% year-over-year, $8,896 million for the full year, up 4.3% year-over-year
TAS Revenue of $1,821 million for the fourth quarter, up 9.8% year-over-year, $6,626 million for the full year, up 7.6% year-over-year
Operating Cash Flow of $735 million, bringing full-year Operating Cash Flow to $2,654 million
Free Cash Flow of $561 mill...
|
|
|
|
|
|
|
30.01.26 - 12:24
|
IQVIA and Boehringer Ingelheim collaborate on therapeutic data transformation (PBR)
|
|
|
As part of this agreement, Boehringer Ingelheim will utilise IQVIA's data-as-a-service (DaaS+) technology to advance its global commercial data transformation, aiming to streamline data management and analytics across
The post IQVIA and Boehringer Ingelheim collaborate on therapeutic data transformation appeared first on Pharmaceutical Business review....
|
|
|
20.01.26 - 22:51
|
IQVIA to Announce Fourth-Quarter and Full-Year 2025 Results on February 5, 2026 (Business Wire)
|
|
|
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, will announce its fourth-quarter and full-year 2025 financial results before the market opens on Thursday, February 5, 2026. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at: http://ir.iqvia.com.
To listen to the event and view the presentation slides via webcast, join via the IQVIA Investor Relations website at: http://ir.iqvia.com. To participate in the conference call, interested parties must register in advance by registering on http://ir.iqvia.com. Following registration for the call, participants will receive a confirmation email containing details on how to join the conference ca...
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
